Log in to save to my catalogue

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertens...

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertens...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8e50277bf2c448aa930fb3478374f053

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

About this item

Full title

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-01, Vol.15 (1), p.330-330, Article 330

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Pulmonary arterial hypertension (PAH) is characterised by pulmonary vascular remodelling causing premature death from right heart failure. Established DNA variants influence PAH risk, but susceptibility from epigenetic changes is unknown. We addressed this through epigenome-wide association study (EWAS), testing 865,848 CpG sites for association wi...

Alternative Titles

Full title

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8e50277bf2c448aa930fb3478374f053

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8e50277bf2c448aa930fb3478374f053

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-44683-0

How to access this item